Patient and Provider Assessment of Lipid Management Registry

Inclusion Criteria: 1. Prior evidence of clinical atherosclerotic cardiovascular disease (ASCVD) which can include any of the following: * Hospitalization for acute myocardial infarction or unstable angina * Coronary revascularization or chronic coronary artery disease with or without angina * Other arterial (carotid, abdominal, renal or lower extremity) revascularization (e.g., surgical bypass, percutaneous intervention, arterial vascular reconstruction, abdominal aortic aneurysm repair, excluding dialysis fistulas or arteriovenous grafts). * Ischemic stroke or transient ischemic attack (TIA) * Imaging evidence of \> 70% diameter stenosis in any carotid artery or clinical documentation of severe carotid stenosis * Peripheral arterial disease secondary to atherosclerosis (e.g., aortic aneurysm, ankle brachial index \<0.9, imaging evidence of \>50% diameter stenosis in any peripheral artery, or claudication) 2. Currently on statin therapy 3. Low density lipoprotein cholesterol (LDL-C) level ≥ 130 mg/dL within the last 2 years (treated or untreated) 4. Age ≥ 65 years 5. Age ≥ 40 years with at least 1 of the following: * Diabetes * Chronic Kidney Disease (CKD), defined as eGFR \<60 ml/min or documented stage III or higher CKD * 10-year ASCVD risk ≥ 5% (per the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk) * 2 or more of the following characteristics: Male sex; Systolic BP \> 140 mmHg or on medication for hypertension; Current tobacco use Exclusion Criteria: 1. Unable or unwilling to provide informed consent, including but not limited to cognitive or language barriers (reading or comprehension) 2. Anticipated life expectancy less than 6 months 3. Participation in any clinical trial involving a medical treatment at the time of enrollment